ARYX

ARYx Therapeutics, Inc. ARYX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ARYX AOLS INSO VFRM NUGS NNRX HCANF ITMC MPXOF ATTBF
6M 0.00 % 0.00 % 0.00 % -50.00 % 0.00 % 4 900.00 % 0.00 % -94.29 % 0.00 % -70.00 %
YTD 0.00 % -66.67 % 0.00 % -87.50 % 9 900.00 % -50.00 % 0.00 % -92.86 % -90.91 % -70.00 %
1Y 0.00 % 0.00 % -95.00 % -95.00 % 9 900.00 % -50.00 % 0.00 % -97.06 % 0.00 % 2 900.00 %
3Y 0.00 % 0.00 % -99.50 % -99.41 % -98.46 % -75.00 % -99.89 % -99.62 % -97.97 % -70.00 %
5Y -86.11 % -93.75 % -99.77 % -99.97 % -99.84 % -50.00 % -100.00 % -99.93 % -99.86 % -99.62 %
10Y -84.85 % -99.96 % -100.00 % -99.99 % -99.85 % -93.75 % -100.00 % -99.99 % -99.98 % -99.93 %
From the beginning -99.99 % -100.00 % -100.00 % -99.99 % -99.92 % -99.96 % -100.00 % -100.00 % -99.98 % -99.97 %

Dividend